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a b s t r a c t
The basic helix–loop–helix (bHLH) transcriptional activator Ptf1a determines inhibitory GABAergic over
excitatory glutamatergic neuronal cell fate in progenitors of the vertebrate dorsal spinal cord, cerebellum
and retina. In an in situ hybridization expression survey of PR domain containing genes encoding putative
chromatin-remodeling zinc ﬁnger transcription factors in Xenopus embryos, we identiﬁed Prdm13 as a
histone methyltransferase belonging to the Ptf1a synexpression group. Gain and loss of Ptf1a function
analyses in both frog and mice indicates that Prdm13 is positively regulated by Ptf1a and likely
constitutes a direct transcriptional target. We also showed that this regulation requires the formation
of the Ptf1a–Rbp-j complex. Prdm13 knockdown in Xenopus embryos and in Ptf1a overexpressing
ectodermal explants lead to an upregulation of Tlx3/Hox11L2, which speciﬁes a glutamatergic lineage and
a reduction of the GABAergic neuronal marker Pax2. It also leads to an upregulation of Prdm13
transcription, suggesting an autonegative regulation. Conversely, in animal caps, Prdm13 blocks the
ability of the bHLH factor Neurog2 to activate Tlx3. Additional gain of function experiments in the chick
neural tube conﬁrm that Prdm13 suppresses Tlx3þ/glutamatergic and induces Pax2þ/GABAergic
neuronal fate. Thus, Prdm13 is a novel crucial component of the Ptf1a regulatory pathway that, by
modulating the transcriptional activity of bHLH factors such as Neurog2, controls the balance between
GABAergic and glutamatergic neuronal fate in the dorsal and caudal part of the vertebrate neural tube.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The dorsal spinal cord is an integrative center that transmits
and processes diverse somatosensory information. These neurons
can be grouped into excitatory neurons and inhibitory neurons,
which use glutamate and GABA/glycine as transmitters respec-
tively. These inhibitory and excitatory neurons are interconnected
and a correct balance between them is essential for correct
processing of somatosensory inputs from the periphery. Six dis-
tinct classes of dorsal interneurons (early dI1-6 and late dILA
and dILB) arise in the dorsal spinal cord from six progenitor
domains (dP1-6). Among them, early-born dI4 and dI6 and late-
born dILA neurons are GABA/glycinergic neurons (Helms and
Johnson, 2003; Hori and Hoshino, 2012). These three classes of
postmitotic interneurons express the homeodomain transcription
factors Lbx1, Pax2 and Lhx1/5 that regulate GABA/glycinergic
differentiation (Pillai et al., 2007; Batista and Lewis, 2008; Bröhl
et al., 2008).
While postmitotic dorsal interneurons can be distinguished
by the combinatorial expression of homeodomain transcription
factors, bHLH factors have a crucial role in progenitors in the
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speciﬁcation of excitatory versus inhibitory neurons. Ptf1a (pan-
creas transcription factor 1a), a bHLH transcriptional activator
initially identiﬁed as a cell fate determinant of the pancreas
(Krapp et al., 1998; Kawaguchi et al., 2002; Sellick et al., 2004;
Afelik et al., 2006) that is restricted to dI4 and DILA interneuron
progenitors in the dorsal spinal cord, plays an essential role in the
speciﬁcation of GABAergic and glycinergic inhibitory neurons
while suppressing glutamatergic excitatory neurons. Mice lacking
Ptf1a show a near complete loss of dI4 and dILA GABAergic
interneurons and an increase of dI5 and dILB excitatory interneur-
ons. Conversely, overexpression of Ptf1a in the chick neural tube
induces GABAergic and glycinergic neurons at the expense of
Tlx3-positive glutamatergic excitatory dI5 and dILB neurons
(Glasgow et al., 2005; Hori et al., 2008; Huang et al., 2008). The
requirement for Ptf1a in the generation of GABAergic and glyci-
nergic inhibitory neurons has been also demonstrated in other
regions of the developing CNS where it is expressed, including the
cerebellum, cochlear nucleus and the retina (Hoshino et al., 2005a,
2005b; Fujitani et al., 2006; Nakhai et al., 2007; Pascual et al.,
2007; Dullin et al., 2007; Fujiyama et al., 2009). Ptf1a has been
shown to be required for Pax2, Lhx1 and Lhx5 expression and for
the suppression of glutamatergic cell fate determinants Tlx3 (also
known as Rnx and Hox11L2) and Lmx1b (Cheng et al., 2004, 2005;
Hori et al., 2008). The molecular mechanism by which Ptf1a
activates one lineage speciﬁc gene expression and represses
expression of genes of the other alternate lineage remains unclear.
Ptf1a is a component of a heterotrimeric transcription complex,
called PTF1-J, that includes Ptf1a, a commonly expressed bHLH E-
protein and a member of the mammalian Suppressor of Hairless
family, Rbp-j (or its paralogue, Rbp-l, to form PTF1-L in the pancreas)
that mediates Notch signaling (Beres et al., 2006; Masui et al., 2007).
This PTF1-J transcription complex is required in vivo for the speciﬁca-
tion of GABAergic neurons in a Notch signaling independent manner
(Hori et al., 2008). The PTF1-J complex binds a bipartite DNA
sequence composed of an E-box for bHLH heterodimer binding and
a TC-box for Rbp-j binding. Only a few direct targets of the PTF1-J
complex in the dorsal spinal cord have been identiﬁed so far. These
include Nephrin and Neph3 genes encoding immunoglobulin type
transmembrane proteins, whose function in the development of
Ptf1a expressing GABAergic interneurons is unknown (Nishida et al.,
2010) and Ptf1a itself (Meredith et al., 2009; Masui et al., 2008). The
atonal related bHLH proneural gene Neurog2, which is broadly
expressed in dorsal interneurons, is another direct downstream
target of PTF1-J (Henke et al., 2009). Embryos null for both Neurog2
and another member of the bHLH family, Ascl1 (Mash1), coexpressed
with Neurog2 in dP3-dP5 progenitors, have an apparent loss of dI4
neurons. This phenotype is however not observed in the single
mutant embryos (Helms et al., 2005) suggesting that Neurog2 has a
redundant function with Ascl1 in dP4. As Ascl1 is not affected in Ptf1a
mutants, this suggests that additional targets of Ptf1a need to be
identiﬁed to understand the dramatic loss of the dI4 cells observed in
Ptf1a mutants (Henke et al., 2009).
In an in situ hybridization expression survey of the expression
of PR domain containing genes in the Xenopus embryo, the
expression proﬁle of the Prdm13 gene was found to overlap with
that of Ptf1a in the developing spinal cord and retina. Prdm13
encodes a protein containing a N-terminal PR domain related to
the SET domain found in a large group of histone methyltrans-
ferases, followed by four zinc ﬁnger repeats (Huang et al., 1998;
Albert and Helin, 2010). Prdm13 belongs to the Prdm gene family
consisting of 16 orthologs in rodents, birds and amphibians that
encodes important regulators in differentiation and disease. Prdm
family members recognize speciﬁc DNA-sequences or act as
non-DNA binding cofactors. They either function as direct histone
methyltransferases (HMTases) or recruit histone-modifying enzyme
to target promoters (Fog et al., 2011; Hohenauer and Moore, 2012).
Recent reports have shown that some vertebrate Prdm family
members play important roles as cell fate regulators in the
developing nervous system. For example, Prdm1/Blimp1 speciﬁes
photoreceptor over bipolar neurons in the mouse and zebraﬁsh
retina (Brzezinski et al., 2010; Katoh et al., 2010). It also controls
cell fate decision at the neural plate border in zebraﬁsh embryos
(Roy and Ng, 2004; Hernandez-Lagunas et al., 2011). Prdm8
regulates target gene expression in postmitotic cortical neurons
by forming a repressor complex with the transcription factor
Bhlhb5 (Ross et al., 2012). Hamlet, the Drosophila Prdm3/Evi1 and
Prdm16/Mel1 homolog controls olfactory receptor neuron diversi-
ﬁcation by modulating Notch signaling (Endo et al., 2011).
Here, we identify the HMTase Prdm13 as a likely direct target of
the Ptf1a–Rbp-j complex. We show that Prdm13 negatively reg-
ulates its own expression and that it plays an important role
downstream of Ptf1a in the suppression of glutamatergic and
induction of GABAergic differentiation. We also provide evidence
suggesting that Prdm13 represses glutamatergic neuronal fate by
blocking Neurog2 ability to induce the glutamatergic-neuron
speciﬁer Tlx3 gene.
Materials and methods
Expression constructs
The mPrdm13 expression vector used in frog microinjection
experiments was obtained by PCR amplifying from EST BY731300,
clone E130110K18, using primers 50- GAATCGCACGGAACTTCTCG-
CACTTCG-30 and 50-AGAATGCTTTCAGAATGAGAGGCTATGCCA-
GAGTCT-30 a 2359 bp fragment containing an open reading
frame starting from the second methionine (position 49 in
supplementary material Fig. S1, corresponding to the ﬁrst methio-
nine in the other species) into the EcoRI and XhoI sites of the
pCS2-Flag vector. The mPrdm13 expression construct used in chick
electroporation was generated by PCR amplifying from the same
EST using primers 50-CTCGAGCCCGAGCGTCTGCCTGGC-30 and 50-
GAATTCCTGGTCCCTGCTCAGTCCCT-30 a 2190 bp fragment contain-
ing an open reading frame starting from the second methionine
into the XhoI and EcoRI sites of the pCIG vector.
MT-Ptf1apCS2þ , MT-Ptf1aW224ApCS2þ , MT-Ptf1aW242ApCS2þ
and MT-Ptf1aW224A/W242ApCS2þ were generated by PCR ampliﬁ-
cation using the following primers: forward 50-CAGAATTCCATG-
GAAACGGTCC-30 and reverse 50-CCCTCTAGATCACATATCAAGGCAC-
30. The PCR fragments were inserted into the EcoRI and XbaI sites
of the MTpCS2þ vector.
Ptf1aW224A–GRpCS2þ , Ptf1aW242A–GRpCS2þ and Ptf1aW224A/
W242A–GRpCS2þ were generated using the “QuickChange XL Site
directed Mutagenesis” kit (Stratagene) to introduce mutations
that lead to an exchange of tryptophan to alanine at position 224
and/or 242 using the following primers: C1_up GGACATTCTCTCT-
CAGCGACTGATGAGAAGCAACTGAG, C1_down CTCAGTTGCTTCTCAT-
CAGTCGCTGAGAGAGAATGTCC, C2_up GTTGTCAGAACGGCCAAAGTG-
GCGACTCCTGAGGATCC, C2_down GGATCCTCAGGAGTCGCCAC-
TTTGGCCGTTCTGACAAC. Rbp-J–HApCS2þ was generated by PCR
ampliﬁcation using the following primers: forward 50-CTGGATC-
CATGCAACCTGGC-30 and reverse 50-CAACTCGAGGGACACTACT-
GCTGC-30. The PCR fragment was inserted into the BamHI and XhoI
sites of the HApCS2þ vector. Ptf1a/bHLH-Neurog2-GRpCS2 was
generated by ﬁrst amplifying the bHLH domain of Neurog2 (GR-
Neurog2p30, Perron et al., 1999) with the following primers, which
contained the surrounding sequences of the Ptf1a bHLH domain
(in italics): Ptf1a/bHLH-Neurog2_for CTGAGGTCGGACGCGGAGATG-
CAGCAGCGGCGCGTTAAAGCTAACAAC and Ptf1a/bHLH-Neurog2_rev
GCGGCAGATCGGACTGTACCATCTCGCTAAGAGCCCAGATGTAGTTGTAG.
The generated megaprimer were used in a second PCR reaction
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with the “QuickChange XL Site directed Mutagenesis” kit (Strata-
gene) and Ptf1a-GRpCS2þ (Afelik et al., 2006).
Histone methyltransferase (HMTase) assay
The HMTase assay was conducted as reported (Eom et al.,
2009), with some minor modiﬁcations. Brieﬂy, Flag-Prdm13 was
overexpressed in HEK 293T cells. 24 h post-transdection, total
protein extracts were prepared in IPH buffer (50 mM Tris/HCl pH
8, 150 mM NaCl, 0.5% NP-40, 1 mM DTT) and precleared with
protein-A sepharose beads (GE healthcare) for 1 h at 4 1C. Subse-
quently, precleared cell extracts were incubated overnight with
Flag antibody and for 2 h at 4 1C with protein-A sepharose beads.
After three washes with IPH buffer containing 500 mM NaCl, the
beads were incubated in a 35 ml of reaction mixture containing
3 mg of chicken core histones (Millipore) as a substrate for enzyme
activity, 1.1 mCi of S-adenosyl-[methyl-3 H]-L-methionine (Perkin
Elmer) in HMTase assay buffer (50 mM Tris, pH 8.0, 1 mM EDTA,
50 mM NaCl, 1 mM MgCl2, 1 mM DTT), containing protease inhi-
bitors (complete EDTA free from Roche). After 2 h of incubation at
30 1C under agitation, proteins were ﬁltered using p81 paper
(Phosphocellulose Squares) (Millipore), and washed three times
with 10% TCA and 100% ethanol for 5 min in RT. The ﬁlters were
allowed to air dry. Five ml of OptiPhase ‘Hisafe’ 2 (PerkinElmer)
was then added to the ﬁlters. Quantiﬁcation was done on a LS
6500 liquid scintillation counter (Beckman).
In vitro co-immunoprecipitation
For the co-immunoprecipitation, Rbp-J-HApCS2þ , MT-
Ptf1apCS2þ , MT-Ptf1aW224ApCS2þ , MT-Ptf1aW242ApCS2þ and
MT-Ptf1aW224A/W242ApCS2þ were in vitro translated and radio-
actively labeled with 35S methionine using the Promega TNT
Coupled Reticulocyte lysate systems. Immunopellets were pre-
pared by incubating γ-bind sepharose beads (Amersham) with
anti-HA.11 (Covance) in NET-2 buffer (50 mM Tris–HCl, pH 7.4,
150 mM NaCl, 0.05% NP-40) for 2 h at 4 1C and subsequent
washing for four times with 500 μl NET-2 buffer. The immunopel-
lets were incubated with 2 μl of the in vitro synthesized proteins
for 1 h at 4 1C and ﬁnally washed four times with 700 μl NET-2
buffer. After boiling the immunopellets for 5 min in 2 SDS
loading buffer, the proteins were separated by 12% SDS-PAGE.
Images were acquired using a phosphoimager (Typhoon 9400,
Amersham Biosciences).
Xenopus embryo culture, micro-injections and animal cap dissections
Xenopus embryos were obtained from adult frogs by hormone
induced egg-laying and in vitro fertilization using standard meth-
ods (Sive et al., 2000) and staged according to Nieuwkoop and
Faber (1967). Synthetic mRNAs were made using Sp6 mMESSAGE
mMACHINE. (Ambion). Flag-mPrdm13, Ptf1a/bHLH-Neurog2-GR
and Ptf1aW224A/W242A-GR were linearized with NotI and tran-
scribed with Sp6. Template described previously include: MT-
Neurog2 (Ma et al., 1996), Neurog2-GR (Perron et al., 1999), Ascl1
(Parlier et al., 2008), NeuroD (Lee et al., 1995), Ptf1a-GR (Afelik
et al., 2006) and Ptf1a-VP16 (Dullin et al., 2007), Su(H) (Wettstein
et al., 1997) and nLacZ (Chitnis et al., 1995). The Prdm13 antisense
morpholino (50-ACCCCCAGTAGTTGGCAGTGACAGA-30), Prdm13
antisense mismatch morpholino (50-ACCCCgAcTAcTTGcCAcTGA-
CAGA-30) and control morpholino oligonucleotides were obtained
from Genetools. Ptf1a and Neurog2 antisense morpholinos were as
previously described (Dullin et al., 2007; Klisch et al., 2006). For
in situ analysis, embryos were injected in one cell of two to four-
cell stage embryos, and ﬁxed at neurula, tailbud or early tadpole
stage. In all experiments, embryos were coinjected with LacZ
mRNA (50 pg/blastomere) to reveal the manipulated side. For
animal cap assays, synthesized mRNA was microinjected into the
animal region of each blastomere of four-cell stage embryos.
Animal caps were dissected at blastula stage (st.9) and cultured
in 1X Steinberg medium, 0.1% BSA until sibling embryos reach the
desired stage. To block protein translation, embryos and animal
caps were pretreated at stage 12.5 with 10 mg/ml cycloheximide
(CHX) for 1 h prior to Dex addition (10 mM). The expression of the
different markers was analyzed 24 h later at stages 15–16.
In situ hybridization and immunohistochemistry
Whole-mount in situ hybridization analysis of Xenopus
embryos was performed as described using digoxigenin- or
ﬂuorescein-labeled antisense probes (Sive et al., 2000) generated
as indicated: pBSK(-)-xPrdm13 (EST BJ064589, NotI, T7), pCMV-
SPORT6-xPrdm8 (EST BC136202, SalI, T7), pCMV-SPORT6-Dbx1 (EST
CF287983, SalI, T7), pBKS-Sox3 (EcoRI, T7). The following con-
structs were previously described: Ptf1a, Gad1 (Dullin et al., 2007),
Mafb (Ishibashi and Yasuda, 2001), N-tubulin (Chitnis et al., 1995),
Eng2 (Hemmati-Brivanlou et al., 1991), Krox-20 (Nieto et al., 1991),
Neurog2 (Ma et al., 1996), Pax2 (Heller and Brändli, 1997), Tlx3/
Hox11L2 (Patterson and Krieg, 1999), TH (Parlier et al., 2008). For
sections, embryos after completion of the whole-mount procedure
were gelatine-embedded and vibratome-sectioned at 30 μm thick-
ness. Double ﬂuorescent in situ mRNA hybridization was per-
formed on 12 μm cryostat section as previously described (Lea
et al., 2012). For EdU experiments, stage 42 tadpoles were
incubated 3 h in a 1 mM EdU solution, then immediately ﬁxed in
4% paraformaldehyde. In situ hybridization on 12 μm cryostat
section was performed followed by EdU revelation using Click-iT
EdU Alexa Fluor 488 or 594 Imaging Kit (Molecular Probes).
For section in situ hybridization of mouse embryos, 20 mm
cryostat sections of 4% paraformaldehyde ﬁxed, 30% sucrose/PBS-
infused tissue frozen in gelatin (7,5% gelatin, 15% sucrose/PBS)
were used. In situ hybridizations were performed as previously
described using digoxigenin-labeled antisense Prdm13 (Kinameri
et al., 2008), Pax2 (Dressler et al., 1990) and Neph3 (Nishida et al.,
2010) riboprobes as described (Wilkinson and Nieto, 1993).
For immunoﬂuorescent labeling, ﬁxed electroporated chicken
embryos were cryoprotected with 30% (w/v) sucrose in PBS,
embedded in gelatin (7,5% gelatin, 15% sucrose/PBS) and frozen for
cryo-sectionning (16 mm thickness). Immunolabeling was performed
as described (Francius and Clotman, 2010). The antibodies used were
Pax2 (rabbit, 1:500, ab23345, Abcam), Tlx3, Lmx1b (rabbit, 1:5–10,000
or guinea pig, 1:10–20,000, gift from T.Müller) and Lbx1 (rabbit,
1:10,000, gift from T. Muller). Fixed animal caps were processed with
an anti-Flag (mouse, Sigma F3165,1:1000). In situ hybridization images
were acquired with an Olympus SZX16 stereomicroscope and Olym-
pus XC50 camera, using the Imaging software Cell-Fn. Immunoﬂuor-
escence images were acquired on a Zeiss Axio Imager 2 Fluorescence
microscope or a Zeiss LSM710 confocal microscope, using the Imaging
software Axio visio and Zen2010 respectively.
RT-PCR analysis
Total RNA was extracted using the RNAspin Mini RNA isolation
kit (GE Healthcare). cDNA was synthesized with iScript cDNA
synthesis kit (Biorad), and tested by PCR ampliﬁcation using histone
H4 primers (27 cycles). Real time RT-PCR was performed using the
Step One Plus Real Time PCR system (Applied biosystems) with
MESA GREEN qPCR kits for SYBRs Assay (Eurogentec). Xenopus
GAPDH was used as reference gene and all conditions were
compared to non-injected controls. The following primers were
used: Prdm13 (forward: 50-CTGCCGACACATGATGAAAAAGG-30 and
reverse: 50-AGATTTTGGGGGAGGCAGAAAAG-30); Pax2 (forward:
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50-CAGTCAGCACGCCTGGGCAT-30 and reverse: 50-TGCCTCCAGTTGC-
TGCTGAGT-30); Neurog2 (forward 50-GGCGCGTTAAAGCTAACAAC-30
and reverse 50TTCGCTAAGAGCCCAGATGT-30); Gad1a (forward: 50-
ATGGGCGTCTTACTCCAATG-30 and reverse: 50-ATGTCTACATGGC-
GACCACA-30); Tlx3/Hox11L2 (forward: 50 GCCAACAAGTACAAGTGCA-
CAG-30 and reverse: 50 CAGGAGCCAGACTCACATTGAC-30); Myt1
(forward: 50-TTGGGATGGTCCCATAGACT-30 and reverse 50-TCTTGCA-
TCTCCTGCATCTC-30); Vglut1 (forward: 50-TCAGTGATTTGCTTGT-
TACGTGTAT-30 and reverse: 50-CATCCTCATGGATATTTTCTACACC-
30); Lmx1b (forward: 50-ATCGCTGCTTCACCAGGGGC-30 and reverse:
50-GGCAGTCTGACCCGAGCAGC-30); Lbx1 (forward: 50-GCAGTGCT-
CACCATCTC-30 and reverse 50-CCACATCCTCCTGATCC-30); Histone
H4 (50-CGGGATAACATTCAGGGTATCACT-30 and reverse 50-ATC-
CATGGCGGTAACTGTCTTCCT-30) and GAPDH (forward 50-TAGTTG-
GCGTGAACCATGAG-30 and reverse 50-GCCAAAGTTGTCGTTGATGA-
30). All measurements were done in duplicates or triplicates. Error
bars represent standard deviation. The values in the ﬁgures are
representative cases of at least two independent experiments.
In ovo electroporation
Fertilized chicken eggs were incubated at 38.5 1C in a humidiﬁed
incubator and staged according to Hamburger and Hamilton
(Hamburger and Hamilton, 1992). Embryos were electroporated at
stage HH12-14. The expression constructs (1 μg/μl in endotoxin free
water) dyed with fast green 5X were injected into the lumen of the
spinal cord and electroporated using a BTX square-wave electro-
porator and gold electrodes (5 pulses of 20–25 V for 50 ms each).
Embryos were collected 48 h (HH24-25) or 72 h (HH27-28) after
electroporation and ﬁxed in PBS/4%PFA for 30 min or 1 h, respec-
tively and then processed for immunohistochemistry as above.
Results
Identiﬁcation of Xenopus laevis HMTase Prdm13
In a previous work, we identiﬁed Prdm3 (Evi1) and Prdm16
(Mel1) as zinc ﬁnger genes with localized expression in the
developing embryo, including the nervous system (Van
Campenhout et al., 2006). Sequence homology was used to
identify additional Xenopus laevis orthologs of human and mouse
Prdm genes. Through BLAST searches of the National Center for
Biology Information (NCBI, http://www.ncbi.nlm.nih.gov/) Xenopus
laevis EST database, we identiﬁed four additional members of the
Prdm family, Prdm8, Prdm12, Prdm13 and Prdm14, with restricted
expression in the nervous system. Here we focus on one of them,
Prdm13, during Xenopus development. The detailed expression and
functional analysis of some of the other Prdm orthologs identiﬁed
will be reported elsewhere. The Prdm13 cDNA identiﬁed (EST
BJ064589) was sequenced. The resulting sequence was analyzed
to localize the open reading frame and deduced peptide, and the
annotated sequence was submitted to Genbank (GenBank BankIt
submission ID: 1621537). As the identiﬁed cDNA clone did not
contain the entire open reading frame, we searched the initial
draft assembly of the Xenopus laevis genome and identiﬁed a
scaffold (32494 in genome draft 6.0) containing Prdm13. The
sequence obtained predicts a 633 amino acid protein with 59%
identity to human Prdm13 (accession ♯ NM_021620), 58% to
mouse Prdm13 (accession ♯ NM_001080771), 64% to zebraﬁsh
Prdm13 (accession ♯ XM_001336555) and 92% to the Xenopus
tropicalis Prdm13 predicted protein (accession XM_002932160).
The Xenopus laevis Prdm13 protein has a similar structure to its
homologs in the other species, including a N-terminal PR domain
and four zinc ﬁnger motifs, one located immediately 30 to the PR
domain and the others clustered at the C-terminal end of the
protein. Similarity between the identiﬁed Xenopus laevis, human,
mouse and zebraﬁsh Prdm13 proteins is mainly limited to the PR
and zinc ﬁnger domains (Supplementary material Fig. S1A,B). The
Xenopus laevis Prdm13 gene shows an exon/intron structure
identical to its mammalian and lower vertebrate homologs (4
exons, with the PR domain encoded by exons 1–3 and zinc ﬁngers
1–4 by exon 4), which further supports its orthologous relation to
the other vertebrate Prdm13 genes.
As no Xenopus cDNA clone containing the full Prdm13 open
reading frame is available, we generated a plasmid encoding a
Flag-tagged mouse Prdm13 protein to determine the subcellular
localization of the protein. mPrdm13 mRNA was injected into the
animal pole of fertilized Xenopus embryos at the 2–4 cell-stage. As
expected, the overproduced protein was detected in the nucleus of
the ectodermal cells (Supplementary material Fig. S1C). To deter-
mine whether Prdm13 has histone methyltransferase (HMT)
activity, we overproduced the protein into HEK293 cells. Prdm16
that has HMT activity (Pinheiro et al., 2012) was used as a positive
control. An empty-Flag vector was used to control for non-speciﬁc
binding. Flag proteins were immunoprecipitated using anti-Flag
antibodies and enzymatic HMT activity was measured with the
immunoprecipitated proteins using core histones and [3H]-SAM as
the substrate and methyl donor. As shown in Fig. 1A, Prdm13
increases the incorporation of [3H]-SAM on core histones, as
observed with Prdm16. Thus, as other members of the family,
Prdm13 possess HMT activity.
Prdm13 is expressed in progenitors and post-mitotic cells of the
Xenopus dorsal caudal neural tube and retina
To investigate the Prdm13 temporal expression pattern during
early Xenopus embryogenesis, semi-quantitative RT-PCR was used.
As shown in Fig. 1B, maternal Prdm13 transcripts are detected only
at low levels. Zygotic Prdm13 transcripts are detected starting from
stages 12 to 13, increase until neurula stages and persist later in
tailbud and tadpole stages. The spatial expression of Prdm13 was
analyzed by whole-mount in situ hybridization on embryos at
different stages. Prdm13 transcripts were ﬁrst detected at stage 13
in two bilateral longitudinal stripes running along the posterior
neural plate (Fig. 1C), which were within the sensorial layer of the
neuroectoderm (data not shown). This pattern of expression is
maintained throughout neural fold stages of development. After
neural tube closure, Prdm13 persists in the dorsal part of the
developing posterior hindbrain and spinal cord (Figs. 1D,E).
Expression of Prdm13 was also detectable from stage 25 more
anteriorly in the hindbrain (Fig. 1F, arrowhead), and from stage 28
in the developing retina (Fig. 1G). On transversal sections of stage
32 embryos at the level of the anterior and posterior hindbrain,
Prdm13 is expressed in the ventricular zone of the dorsal spinal
cord but is highest in a more restricted progenitor domain at the
ventricular lateral margin (Figs. 1H and I). At stage 42, strong
Prdm13 expression becomes restricted to the hindbrain (Fig. 1J).
At that stage, in the mature retina, Prdm13 is detected in the inner
part of the inner nuclear layer where GABAergic amacrine cells
reside (Supplementary material Fig. S2A,B,D,E) (Dullin et al., 2007).
To characterize Prdm13 relative to cell proliferation, we used EdU
incorporation to detect cells in S phase. In stage 42 embryos
exposed to EdU 3 h before analysis, a subset of Prdm13 labeling in
the neural tube was found overlapping the EdUþ staining (Fig.1K).
In the retina, Prdm13 was also detected in some EdUþ cells in the
ciliary marginal zone (CMZ) (Supplementary material Fig. S2C).
These data suggest that in the frog neural tube and retina, Prdm13
is expressed in progenitors and post-mitotic differentiating cells.
J. Hanotel et al. / Developmental Biology 386 (2014) 340–357 343
Fig. 1. HMTase activity and developmental expression of Prdm13. (A) mPrdm13 is a histone methyl-transferase. Core histones were used as substrates in a HMTase assay with
a immunopuriﬁed Flag-Prdm13 protein produced in 293T cells. Flag-Prdm16 was used as a positive control. Empty vector transfected cells were used to control for
nonspeciﬁc background. The results represent the average of triplicate samples plus SD. The amount of immunoprecipitated Prdm16 and Prdm13 proteins used in the assay is
shown on the western on the right (arrows). Note thatmPrdm13 is expressed at a much lower level thanmPrdm16. On the autoradiograph shown, multiple bands are seen for
mPrdm16 due to the high exposure time used to detect mPrdm13. Those bands likely correspond to mPrdm16 degradation products. A non-speciﬁc IgG band is indicated by
an arrowhead. (B) Temporal embryonic expression of Xenopus laevis Prdm13 as determined by RT-PCR. Histone H4 is shown as a loading control. (C–K) Whole-mount in situ
analysis of Prdm13 expression during embryogenesis. Panel E, transversal section of the neural tube of a stage 22 embryo. Panels H and I, transversal sections of the neural
tube of a stage 32 embryo at the levels indicated in G. In panel K, transversal section of the neural tube of an embryo that has been additionally stained for proliferation by
EdU incorporation. The enlargement in the inset shows that some Prdm13 are EdU positive. Nieuwkoop Faber stages are indicated. All embryos shown are with anterior to
the right. (C, D) Dorsal views. (F, G, J) Lateral views.
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To map the anterior and dorso-ventral limits of Prdm13
expression in neurula and early tailbud stage embryos, we
compared Prdm13 expression to that of other regionalized neural
markers using double in situ hybridization. For the anteroposterior
axis, we used engrailed-2 (Eng2), expressed speciﬁcally at the
midbrain–hindbrain boundary (Hemmati-Brivanlou et al., 1991),
Krox-20 expressed speciﬁcally within rhombomeres 3 and 5 of the
developing hindbrain (Bradley et al., 1993) and Mafb expressed in
rhombomeres 5 and 6 (Sturgeon et al., 2011). We found that
Prdm13 expression lies caudally to the En2 and Krox20 domains of
expression, with a gap of the size of about one rhombomere
between the anterior limit of Prdm13 and Krox20 within rhombo-
mere 5 (Supplementary material Fig. S3A,B). Double in situ with
Mafb showed that Prdm13 expression terminates at the domain of
Mafb expression and thus has an anterior limit at rhombomere 7
(Supplementary material Fig. S3C).
To determine the position of the stripe of Prdm13 within the
neural plate, we compared its expression with that of N-tubulin,
Dbx1 and Prdm8 by double in situ hybridization. N-tubulin is a
neuronal marker expressed in the three longitudinal stripes
marking the positions of the differentiated primary neurons (Ma
et al., 1996). Dbx1 is expressed in p0 progenitors and marks the
ventral limit of Prdm13 expression in the mouse spinal cord
(Kinameri et al., 2008). In the frog, the homolog of Dbx1 is detected
in between the medial and intermediate stripes of primary
neurons within the Xenopus neural plate (Gershon et al., (2000)).
Prdm8 marks ventral interneurons and motor neurons in the
mouse spinal cord (Komai et al., 2009). Double labeling of neurula
embryos with Prdm13 and N-tubulin revealed that Prdm13 is
expressed in the intermediate stripe where differentiating primary
interneurons are located (Supplementary material Fig. S3D). Dou-
ble in situ with Prdm8 showed that Prdm13 expression is detected
more laterally within the neural plate than Prdm8 (Supplementary
material Fig. S3E). Double labeling with Dbx1 showed that Prdm13
is expressed at the lateral boundary of the Dbx1 domain. Later,
within the neural tube, Prdm13 is detected in the dorsal half, above
the Dbx1 expression domain (Supplementary material Fig. S3F–H).
Thus, similar to mouse and zebraﬁsh Prdm13 (Kinameri et al.,
2008; Sun et al., 2008), Xenopus Prdm13 is only expressed in the
caudal neural tube where it is restricted to the dorsal region.
Prdm13 expression is related to that of Ptf1a in the dorsal neural tube
and retina
Comparing Prdm13 expression to that of the different known
bHLH transcription factors controlling neuronal speciﬁcation, we
found that the Prdm13 expression proﬁle we identiﬁed in the early
frog embryo is strikingly related to that of Ptf1a (Afelik et al.,
2006). Indeed, as shown in Fig. 2A–F, at around stage 18, Ptf1a and
Prdm13 are both detected along two parallel longitudinal stripes
representing the caudal neural folds. At tailbud stage, both Ptf1a
and Prdm13 become expressed in the anterior hindbrain. At that
stage, expression of Ptf1a become less detectable in the caudal
neural tube while Prdm13 remains high. At tadpole stage, Prdm13
is detected in the retina and the anterior hindbrain like Ptf1a but
not in the pancreas, the other major site of Ptf1a expression (data
not shown). To determine whether Prdm13 expression overlaps
with that of Ptf1a, we performed ﬂuorescent double in situ
hybridization on cross-sections of tadpole stage embryos.
Fig. 2G–I shows that in the spinal cord, the expression of Prdm13
overlaps with that of Ptf1a. Within the retina, Ptf1a and Prdm13 are
also coexpressed in the central ciliary marginal zone (CMZ)
(Supplementary material Fig. S2D, F–I).
In the mouse dorsal spinal cord, the expression of Ptf1a is
restricted to the dP4/dILA progenitor domain of the ventricular
zone where it promotes inhibitory neuron differentiation. Its
downstream direct target Neurog2 which is broadly expressed in
the spinal cord is enriched in the lateral regions of the ventricular
zone (Helms et al., 2005; Henke et al., 2009). Pax2, which is
required for Ptf1a to specify an inhibitory neuronal cell fate, is
expressed in dI4/ dILA as well as in dI6 dorsal interneurons and in
ventral interneurons (Huang et al., 2008). To determine if those
Ptf1a downstream targets are expressed in a similar manner in the
Xenopus caudal neural tube and determine whether Prdm13 over-
laps with them, we compared by whole-mount in situ hybridiza-
tion their expression. On transversal sections of the hindbrain in
stage 32 embryos, as in mouse, Ptf1a is detected with Prdm13,
Neurog2 and Pax2 at similar D/V levels in the dorsal part of the
neural tube (Fig. 2J–M). While Ptf1a appears expressed in the
lateral part of the ventricular zone and in the intermediate zone,
Prdm13 strongest expression, like that of Neurog2, is detected
slightly more laterally in the intermediate zone, where cells start
to differentiate. Pax2 is detected in the marginal zone containing
post-mitotic cells. These results suggest that Prdm13 may act
downstream of Ptf1a, at about the same time as Neurog2, and
before Pax2 during neuronal differentiation.
Ptf1a regulates Prdm13 expression in the spinal cord
To address a possible role of Ptf1a in the regulation of Prdm13
expression within the developing neural tube, we ﬁrst used gain of
function experiments. mRNAs encoding glucocorticoid inducible
forms of Ptf1a (Ptf1a-GR) or of Ptf1a-VP16-GR encoding a Ptf1a
variant where the strong VP16 transactivation domain is fused to
the carboxyl-terminus of Ptf1a were injected into one blastomere
of two-cell stage embryos together with LacZ mRNA to localize the
distribution of the injected mRNA. Dexamethasone (DEX) was
added at stage 12.5. Embryos were analyzed by whole mount
in situ hybridization for Prdm13 at neurula and tadpole stages. The
GABAergic marker Pax2, a known downstream target of Ptf1a in
the mouse (Glasgow et al., 2005) was used as a control. As shown
in Fig. 3, Ptf1a-GR overexpression increases Prdm13 expression in
neurula and tadpole stage embryos. At neurula stage, Prdm13
expression was increased within its normal expression domain.
Ectopic expression was also detected within the ectoderm, the
strongest staining being observed in the anterior part of the neural
plate (98%, n¼40). At tadpole stage, ectopic Prdm13 staining was
still detected in the ectoderm (95%, n¼42). Pax2 expression was as
expected also upregulated by Ptf1a overexpression at both neurula
(90%, n¼41) and tadpole (100%, n¼28) stages (Fig. 3A–D). An even
more dramatic increase of Prdm13 and Pax2 was observed upon
injection of Ptf1a-VP16mRNA in both neurula (Prdm13: 91%,
n¼45; Pax2: 100%, n¼27) and tadpole stage embryos (Prdm13:
100%, n¼48; Pax2: 100%, n¼16). In those Ptf1a-VP16 injected
tadpoles, Prdm13 upregulation was only detected in the dorsal
part of the neural tube. Strikingly, Prdm13 expression was also
observed in some embryos in somitic tissue, which was not the
case for Pax2 (Fig. 3E–H). Although much less dramatic, an
upregulation of Prdm13, was also observed in embryos overex-
pressing Ascl1 (Xash1) that, like Ptf1a, induces GABAergic neurons
(Mazurier et al., unpublished) (Supplementary material Fig. S4).
Because Neurog2 is a direct target of Ptf1a (Henke et al., 2009) and
that it is coexpressed with Prdm13 in the dorsal spinal cord of frog
embryos (Fig. 2K,L), we also examined Prdm13 expression in response
to increase expression of Neurog2 as above using an inducible form of
the protein (Neurog2-GR). Prdm13 expression was mainly unaffected
by overexpression of Neurog2 in embryos at neurula (all unaffected,
n¼29) or tadpole stages (95% unaffected, n¼55). Pax2 was also
mainly unaffected by Neurog2 overexpression (all unaffected, n¼26
at neurula and 95% unaffected, n¼44 at tadpole stage) (Fig. 3I–L). In
contrast, the pan-neuronal marker N-tubulin and the glutamatergic
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marker Tlx3/Hox11L2 were, as previously reported (Perron et al., 1999;
Dullin et al., 2007), strongly increased in those Neurog2mRNA-
injected embryos (data not shown). A downregulation of Prdm13
was even observed in embryos overexpressing a non-inducible
form of Neurog2 or the downstream proneural gene NeuroD that, like
Neurog2, promotes in the Xenopus ectoderm a glutamatergic fate
(supplementary material Fig. S4). The regulation of Prdm13 by Ptf1a
and Neurog2 was further investigated in ectodermal explants. These
explants are fated to become epidermis but can be converted to
derivatives of all three germ layers. Embryos were injected bilaterally
with mRNA at the two cell-stage, and animal caps dissected at blastula
stages. Total RNAwas analyzed at stage 16 by RT-qPCR. As observed in
embryos, Ptf1a but not Neurog2 strongly induces Prdm13. We also
analyzed the ability of the GABAergic inducer Ptf1a to induce Prdm13
when co-injected with Neurog2 that only induces in this assay
glutamatergic markers (Dullin et al., 2007). We found that Prdm13 is
more prominently induced in caps derived from embryos overexpres-
sing both Ptf1a and Neurog2 compared to those derived from embryos
injected with Ptf1amRNA alone, suggesting an unexpected synergistic
effect (Supplementary material Fig. S5).
To determine whether Ptf1a and Neurog2 are required for
Prdm13 expression, we used antisense morpholinos that have
been shown previously to be efﬁcient and speciﬁc to knockdown
their function (Klisch et al., 2006; Afelik et al., 2006; Dullin et al.,
2007). Embryos injected with the Ptf1a-MO or Neurog2-MO
were analyzed at neurula and tadpole stages for Prdm13 expres-
sion. Pax2 was also examined at tadpole stage embryos as a
control for the Ptf1a-MO. A reduction of Prdm13 was detected on
the injected side within the neural plate (71% reduced, n¼57) of
Ptf1a-MO injected embryos. A similar reduction was observed in
the neural tube of Ptf1a-MO injected tadpole stage embryos
(91% reduced, n¼48). Pax2 was as expected strongly reduced
Fig. 2. Prdm13 embryonic expression proﬁle is highly related to that of Ptf1a and overlaps with those of its downstream targets Neurog2 and Pax2 in Xenopus embryos. (A–F)
Dorsal or lateral views of Prdm13 and Ptf1a in stage 18, 27 and 33 embryos showing that the two genes have a similar restricted expression in the neural tube. (G–I) Images of
transversal sections of the neural tube at the level of the anterior spinal cord of a stage 32 embryo, following double ﬂuorescent in situ hybridization for Prdm13 and Ptf1a. Note
the overlap of the two stainings (arrows). (J–M) Transversal sections of the neural tube of stage 32 embryos at the level of the otic vesicles stained with the indicated probes.
Note that Ptf1a appears coexpressed with Prdm13, Neurog2 and Pax2 in the dorsal neural tube. While Ptf1a is expressed in the lateral part of the ventricular zone and in the
intermediate zone, Prdm13 and Neurog2 strongest expression is detected in the intermediate zone and Pax2 in the marginal zone. Nieuwkoop Faber stages are indicated.
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following Ptf1a-MO injection (all reduced, n¼ 46) (Fig. 3M–O).
In embryos injected with the Neurog2-MO, Prdm13 remains
mainly unaffected (85% unaffected and 15% slightly reduced,
n¼55 at neurula stage and 92% unaffected and 8% reduced,
n¼49 at tadpole stage). Pax2 was also unaffected (100%, n¼22)
(Fig. 3P–R). The expression of the pan-neuronal marker N-
tubulin was as previously reported (Klisch et al., 2006) inhibited
(data not shown). Together, these data indicate that Ptf1a but not
Fig. 3. Prdm13 is dramatically affected by Ptf1a but not by Neurog2 gain or loss of function in Xenopus. (A–L) In situ hybridization analysis of Prdm13 expression in Ptf1a-GR,
Ptf1a-VP16 or Neurog2-GR injected embryos analyzed at neurula and tadpole stages. Pax2was used as a control. At neurula stage, embryos are shown in dorsal views, anterior to
the bottom. At tadpole stage, transversal sections at the level of the posterior hindbrain or spinal cord are shown. The arrow in G indicates ectopic Prdm13 in the somites. (M–R)
In situ hybridization analysis of Prdm13 expression in embryos injected with 20 ng of a Ptf1a-MO or a Neurog2-MO. Pax2 was used as a control for the Ptf1a-MO. Prdm13
expression was analyzed at the open neural plate stage and in the neural tube of tadpole stage embryos. Pax2 was only analyzed at tadpole stage. Note that Prdm13 like Pax2 is
reduced in Ptf1a-MO injected embryos and is largely unaffected in Neurog2-MO injected embryos. In all cases, LacZ mRNA was used as a lineage tracer. IS, injected side.
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Neurog2 is a critical regulator of Prdm13 expression in the dorsal
neural tube.
Prdm13 is a likely direct Ptf1a transcriptional target
To determine whether Prdm13 regulation by Ptf1a is likely to be
direct or not, we ﬁrst measured in animal caps the temporal induction
of Prdm13 induction by Ptf1a-GR compared to that of Pax2, an indirect
Ptf1a target. At stages 9–10, animal cap explants were either left
untreated or exposed to DEX for 1–6 h before harvesting. We observed
a slight increase of Prdm13 expression (4-fold induction) already after
2 h of treatment of DEX and a dramatic induction (1300-fold induc-
tion) later, which is in accordance with the idea that it may be induced
directly by Ptf1a. By contrast, signiﬁcant Pax2 induction was not
detected, even at the latest time points analyzed (Fig. 4A). We next
asked if Ptf1a-GR could induce Prdm13 expression in the presence of
cycloheximide (CHX), a protein synthesis inhibitor. Therefore, embryos
were injected unilaterally at the two-cell stage with Ptf1a-GR mRNA,
together with LacZ mRNA as a tracer. At stage 12.5, embryos were
cultured for 1 h in the presence or absence of CHX, before exposure to
DEX until stages 15–16 and then processed by in situ hybridization for
Prdm13 and Pax2 expression. This CHX pretreatment has been shown
to be efﬁcient to reduce protein synthesis (Wettstein et al., 1997).
Under the conditions used, this treatment appears to last for a
sufﬁciently long time as it did block the indirect Ptf1a target Pax2
(96% induced, n¼28 in non-CHX pretreated embryos; 97% uninduced,
n¼41 in CHX pretreated embryos). In contrast, this treatment did not
prevent activation of Prdm13 (all induced in both untreated and CHX
pretreated embryos, n¼45 and 51, respectively) (Fig. 4B). To conﬁrm
this, we repeated the Ptf1a-GR induction assays in the presence or
absence of CHX pretreatment in animal caps. Explants expressing
Ptf1a-GR were incubated at stage 12.5 for 1 h in the presence of CHX
before DEX treatment and then used for RT-qPCR analysis at the
equivalent of stages 15–16. Fig. 4C shows that Prdm13 is slightly
upregulated by CHX treatment (6 fold increase), suggesting that some
negative regulators may turn over rapidly and therefore disappear in
the presence of CHX. DEX treatment in the presence of CHX also
resulted in a stronger induction of Prdm13, higher than that observed
in DEX alone treated caps. As in embryos, the Ptf1a-induction of Pax2
was completely abolished by CHX treatment. These data suggest that
Ptf1a directly regulates Prdm13. In accordance with this idea, an
analysis of a pancreatic cell line chromatin immunoprecipitation
dataset of Ptf1a genomic binding sites (Geo: GSE27295, Thompson
et al., 2012) revealed two strong binding sites 48 kb upstream and
70 kb downstream of the Prdm13 start site. Although the downstream
site had a Rbp-J binding site (TC-box), it did not show a perfect Ptf1a
binding site (E-box) with the correct spacing of 1–3 helical turns
(Masui et al., 2007; Nishida et al., 2010). However, the upstream peak
had a Ptf1a binding element 1 and 3 helical turns apart from two Rbp-
J (TC-box) binding elements (Supplementary material Fig. S6).
Implication of the bHLH domain of Ptf1a in Prdm13 activation
and GABAergic speciﬁcation
In Xenopus whole embryos and animal cap explants, Ptf1a over-
expression strongly induces GABAergic neurons while Neurog2
Fig. 4. Prdm13 is a likely direct Ptf1a transcriptional target. (A) Real time RT-PCR analysis of Prdm13 expression in animal cap explants derived from Ptf1a-GR overexpressing
embryos either left untreated or exposed to DEX for 1–6 h before harvesting. Pax2, was used as a control. Note that Prdm13 expression is already dramatically induced after
4 h of treatment of DEX. In contrast, Pax2 is not induced at those early time points of induction. CC, control caps. (B) In situ hybridization analysis of Prdm13 and Pax2 in
neurula embryos overexpressing Ptf1a-GR, treated with or without CHX for 1 h at stage 12.5 before the addition (or not) of DEX as indicated. LacZmRNAwas used as a lineage
tracer. Dorsal views are shown, with anterior to the bottom. IS, injected side. (C) Real time RT-PCR analysis of the expression of Prdm13 and Pax2 in animal caps derived from
Ptf1a-GR overexpressing embryos, pretreated or not with CHX before the addition (or not) of DEX as in (B). Note that both in embryos and in animal caps, this CHX treatment
does not reduce Prdm13 induction while Pax2 induction is completely abolished.
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induces glutamatergic neurons (Dullin et al., 2007). The importance
of the bHLH domain of Ptf1a for the GABAergic inducing activity of the
Ptf1-J complex remains unclear. To determine whether the ability of
Ptf1a to induce Prdm13 expression is dependent on some speciﬁc
amino acids of its bHLH domain, we generated a construct encoding a
DEX inducible Ptf1a/bHLH-Neurog2-GR chimeric protein where the
Ptf1a bHLH has been replaced with that of Neurog2. The ability of this
construct to induce Prdm13 was evaluated in embryos. Gad1 was
examined as a control. Ptf1a/bHLH-Neurog2-GR was still able to
induce Prdm13 (95% increased, n¼45) and Gad1 (100% increased,
n¼13), although to a lower extent than wild type Ptf1a-GR (Fig. 5A).
A reduced but still signiﬁcant level of induction of Prdm13 was also
observed in animal caps overexpressing Ptf1a/bHLH-Neurog2-GR
(Fig. 5B). Thus, the bHLH domain of Ptf1a is interchangeable with that
of Neurog2, indicating that sequences outside the bHLH domain
of Ptf1a are most important for its speciﬁc functional properties.
Prdm13 is activated by the Ptf1-J trimeric transcription complex
required for the speciﬁcation of GABAergic and suppression of
glutamatergic neurons
Ptf1a and Rbp-j interact in a complex through two highly
conserved motifs (C1/C2) located in the C-terminus of Ptf1a. This
complex, Ptf1-J, is required for speciﬁcation of GABAergic neurons
and suppression of glutamatergic expressing cells in the chick
neural tube (Hori et al., 2008). In this complex, Ptf1a binds with a
common bHLH protein to an E-box, while Rbp-J binds to a TC box
Fig. 5. Prdm13 is activated by the Ptf1-J transcription complex. (A) In situ hybridization analysis of Prdm13 and Gad1 in embryos injected with Ptf1a-GR, Ptf1a/bHLH-Neurog2-
GR or Ptf1aW224A/W242A-GR. Dorsal views, anterior to the bottom, of neurula embryos are shown for Prdm13. Whole head dorsal views and transverse sections at the level of
the posterior hindbrain are shown for Gad1. (B) Real time RT-PCR analysis of the expression of Prdm13 in stage 16 animal cap explants isolated from embryos overexpressing
Ptf1a-GR, Ptf1a/bHLH-Neurog2-GR or Ptf1aW224A/W242A-GR. Note that Prdm13 is dramatically activated in both assays by Ptf1a and to a lesser extent by Ptf1a/bHLH-Neurog2-GR
but not by Ptf1aW224A/W242A-GR, which is also unable to activate Gad1. (C) In situ hybridization analysis of Prdm13 and Neurog2 in embryos injected with Ptf1a, Rbp-J, or a
combination of Ptf1a and Rbp-J. Dorsal views, anterior to the bottom, of neurula embryos are shown. (D) Real time RT-PCR analysis of the expression of Prdm13 and Neurog2
in stage 16 animal cap explants isolated from embryos overexpressing Ptf1a, Rbp-J, or a combination of Ptf1a and Rbp-J. Note that Rbp-J does not affect Prdm13 nor Neurog2
expression and that the combination of Ptf1a and Rbp-J induces stronger Prdm13 and Neurog2 expression than that induced by Ptf1a alone. In all cases, LacZ mRNA was used
as a lineage tracer to identify the injected side. IS, injected side.
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positioned one or two DNA turns away (Beres et al., 2006; Masui
et al., 2007). To determine whether Prdm13 is induced by the Ptf1-J
complex, we ﬁrst compared the capacity of Ptf1a alone to that of
Ptf1a and Rbp-j to induce Prdm13 in embryos and animal caps.
Neurog2 was also examined as a control. As shown in Fig. 5C,D,
overexpression of Ptf1a in combination with Rbp-j induces higher
Prdm13 transcript levels than Ptf1a alone. As anticipated, Rbp-j
alone was not able to induce Prdm13. Similar results were obtained
in animal cap explants. Neurog2was also more strongly induced by
the simultaneous overexpression of Ptf1a and Rbp-j than by either
alone. To determine whether the Rbp-j interaction domain of Ptf1a
is required for its ability to induce Prdm13 expression, we next
generated a form of Xenopus Ptf1a (Ptf1aW224A/W242A-GR) mutated
within the C motifs of Ptf1a that disrupts its interactionwith Rbp-j,
as described previously for mouse Ptf1a (Beres et al., 2006).
Immunoprecipitation experiments demonstrate that the intro-
duced mutations disrupt in vitro the interaction between Xenopus
Ptf1a and Rbp-j (Supplementary material Fig. S7). Fig. 5A shows
that, in embryos, overexpression of Ptf1aW224A/W242A-GR does not
induce Prdm13 (none induced, n¼30). Gad1 was, as expected, also
unaffected by Ptf1aW224A/W242A-GR (77% non-induced and 23% only
weakly increased, n¼13). This Ptf1aW224A/W242A-GR mutant was
also tested in animal cap assays. Fig. 5B shows that as in embryos,
Ptf1aW224A/W242A-GR is unable to induce Prdm13 in animal caps.
To further validate Prdm13 as a target of the Ptf1-J complex, we
also examined its expression in the mouse Ptf1aW298A mutant
incapable of interacting with Rbp-j (Hori et al., 2008). In Ptf1aW298A
mutant embryos, Prdm13 was strongly reduced in the spinal cord,
as observed in Ptf1a-null embryos. The stronger staining observed
at the lateral border of the ventricular zone of the neural tube was
in particular clearly reduced in both mutant Ptf1a-null and
Ptf1aW298A mutant embryos (Fig. 6A,D,G). Pax2 expression was lost
in dI4 but maintained in dI6 differentiating neurons in both
mutants, as expected (Fig. 6B,E,H). Neph3, another Ptf1a target
(Nishida et al., 2010) was also undetectable in both mutants
(Fig. 6C,F,I). These results reveal that Prdm13 is a target of the
Ptf1-J complex.
Prdm13 is required downstream of Ptf1a for the repression of Tlx3
and the induction of Pax2 and negatively regulates its own expression
The results above suggest that Prdm13 may play a role down-
stream of Ptf1a. To begin to approach its function during neural
development, we ﬁrst used a morpholino antisense oligonucleotide
designed to interfere with Prdm13 translation (Prdm13-MO) to
knockdown endogenous Prdm13 in the embryo (Fig.7A–L). Upon
injection of 5 ng of Prdm13-MO in one blastomere of 2–4 cell stage
embryos, 90% of the embryos (n¼21) showed a reduction of Pax2
expression in the dorsal part of the neural tube at stage 25–28. Gad1
was also reduced in Prdm13-MO injected embryos (data not shown).
By contrast, Tlx3 was found slightly upregulated (75%, n¼28). The
expression of the pan-neural marker Sox3 was unperturbed (none
affected n¼20). Injection of a Prdm13 mismatch MO had no such
Fig. 6. Prdm13 is lost in mouse Ptf1acre/cre and Ptf1aW298A mutant embryos. (A–F) Expression of Prdm13, Pax2 and Neph3 analyzed by in situ hybridization on coronal sections
of the spinal cord of E11,5 Ptf1acre/cre, Ptf1aW298A or Ptf1aþ /þ embryos. Note that the strong staining observed in the lateral domain of Prdm13 expression is lost in both
mutants.
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effect on the expression of these markers (all unaffected for Pax2 and
Sox3, n¼21 and 20 respectively; 92% unaffected, n¼28 for Tlx3).
Surprisingly, Prdm13 was strongly upregulated in those embryos (all
increased, n¼28), suggesting that Prdm13 negatively regulates its
own expression in a feedback loop. No such effects were observed
with injection at the same dose of a Prdm13 mismatch MO (all
unaffected, n¼28). We next examined Prdm13 requirement down-
stream of Ptf1a by simultaneously overexpressing Ptf1a while
Fig. 7. Knockdown of Prdm13 reduces Pax2 and an upregulates Tlx3 in the dorsal neural tube of early tadpole embryos and in Ptf1a overexpressing animal caps. (A–H) Dorsal
view and (I–L) transversal sections at the level of the posterior hindbrain or anterior spinal cord of Prdm13-MO injected embryos hybridized with the indicated probes. Note
that Pax2 is markedly reduced in the dorsal neural tube (arrow) while its more ventral expression domain is unaffected. In contrast, Tlx3 and Prdm13 are upregulated. Sox3 is
unperturbed by injection of the Prdm13-MO. Injection of a Prdm13-MOmis has no effect on the different markers tested. (M-R) Real-time RT-PCR analysis of animal cap
explants isolated from embryos injected with Ptf1a mRNA and morpholinos as indicated and collected when sibling embryos reached stage 26. Note that the knockdown of
Prdm13 inhibits the increase of Pax2 and Gad1 and upregulates Tlx3, Vglut1 and Lmx1b. Such an effect is not seen with a Prdm13-MOmis or a standard control MO (MOctrl).
Prdm13 is also induced by Ptf1a. The activation of Prdm13 by Ptf1a (430 fold activation) is not seen on the graph due to the strong activation in the presence of the Prdm13-
MO (19,000 fold activation). CC, control caps.
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knocking down Prdm13 in animal caps. Explants were treated with
DEX at stage 9, cultured until stage 26 and analyzed by RT-qPCR.
Fig. 7M–R shows that the level of induction of the GABAergic
markers Pax2 and Gad1 was reduced following Prdm13 inhibition.
In contrast, the expression of the glutamatergic markers Tlx3/
Hox11L2, VGlut1 and Lmx1b was upregulated. As observed in
embryos, the level of induction of Prdm13 by Ptf1a was increased
upon Prdm13 depletion. Importantly, the downregulation of Pax2
and the upregulation of Tlx3 and Lmx1b could be partially rescued by
injection of mPrdm13 mRNA, which further validate the observed
phenotype (Supplementary material Fig. S8). Together, these results
indicate that Prdm13 is required downstream of Ptf1a for the
repression of Tlx3 and the induction of Pax2 and that it negatively
regulates its own expression.
Prdm13 blocks Neurog2 ability to induce Tlx3
To further uncover the function of Prdm13, we performed
mPrdm13 gain-of-function assays in the frog. We ﬁrst asked
whether Prdm13 is sufﬁcient to induce GABAergic markers in
animal caps. Supplemental material Fig. S9A shows that over-
expression of mPrdm13 is not sufﬁcient to increase Pax2, Lbx1 and
Gad1 in animal cap explants.
While this manuscript was under review, another study was
published identifying also Prdm13 as a critical regulator of the
balance between inhibitory and excitatory neurons acting down-
stream of Ptf1a in the dorsal spinal cord. In their work, Prdm13 is
proposed to act through interaction with the bHLH factor Ascl1
and the repression of its ability to activate Tlx3. The authors also
suggest that Prdm13 may also function by interfering with other
activators of glutamatergic genes (Chang et al., 2013). We therefore
tested in animal caps whether Prdm13 affects the activity of the
bHLH factor Neurog2, which is known to function in some
contexts in glutamatergic differentiation (Schuurmans et al.,
2004; Winpenny et al., 2011). We found that, as previously
reported (Dullin et al., 2007), Neurog2 overexpression in animal
caps strongly activates the expression of the glutamatergic speci-
ﬁer Tlx3 and pan-neuronal markers such as Myt1 but not Pax2.
Interestingly, this dramatic induction of Tlx3 by Neurog2 was
abrogated by the coexpression of Prdm13. No such effect was
observed on Myt1. Pax2 that is reduced upon Neurog2 overexpres-
sion was slightly upregulated when Prdm13 is coexpressed (Fig. 8).
Thus, Prdm13 speciﬁcally silences Neurog2 transcriptional activity
on the Tlx3 gene.
Prdm13 suppresses glutamatergic and induces GABAergic markers
To further demonstrate a role for Prdm13 in the suppression of
Tlx3 and the induction of Pax2 expression, we misexpressed
Prdm13 in the Xenopus embryos. Injected embryos developed
normally until gastrula stage but then failed to complete gastrula-
tion (Supplementary material Fig. S9B–E). To analyze the conse-
quence of Prdm13 misexpression in the dorsal neural tube and
overcome its effects on early development, we turned to the chick
model that is widely used to overexpress gene in the neural tube
by in ovo electroporation. Embryos were electroporated at stage
HH12–14 with a vector expressing mPrdm13 plus GFP and ana-
lyzed 48 h later (stage HH24–25). Transverse sections of thoracic
neural tube were examined by immunoﬂuorescence for alterations
in neuronal subtype speciﬁcation relative to the non-
electroporated side. We used antibodies against the GABAergic
determinants Pax2 and Lbx1 and against the Tlx3 and Lmx1b
glutamatergic markers. Ectopic expression of Prdm13 resulted in
Pax2þ GABAergic neurons in the dI1-3 and dI5 domains where it
is normally absent (Fig. 9A–C). Lbx1þ neurons that are generated
from dP4–dP6 progenitors were also detected in dI1–3 and vI0–3
upon ectopic expression of mPrdm13 (Fig. 9D–F). Conversely,
Tlx3þ glutamatergic neurons were reduced in the dI3 and dI5
domains (Fig. 9G–I). Similarly, the number of cells expressing
Lmx1b was decreased in dI5 (Fig. 9J–L). Thus, Prdm13 phenocopies
the effects of Ptf1a in vivo, suppressing glutamatergic and inducing
GABAergic markers.
Discussion
The balance between excitatory versus inhibitory fate speciﬁca-
tion during development of the central nervous system is a tightly
regulated process that requires precise transcriptional control, and
an imbalance leads to sensory disorders. In the dorsal spinal cord,
the network of transcription factors required for this process
includes members of the bHLH and HD families. A key transcrip-
tion factor in this process is the bHLH factor Ptf1a that functions in
a complex with the Notch mediator Rbp-j to promote GABAergic
and glycinergic inhibitory cell fates and to suppress a glutamater-
gic excitatory cell fate (Beres et al., 2006; Hori et al., 2008). Ptf1a is
known to promote genes encoding transcription factors such as
Pax2 required for the formation of GABAergic neurons and to
suppress Tlx3, an important determinant for glutamatergic cell fate
(Hori and Hoshino, 2012). However, how Ptf1a operates to fulﬁll
Fig. 8. Real-time RT-PCR analysis of animal cap explants isolated from embryos injected with Neurog2 and Prdm13 mRNA as indicated and collected when sibling embryos
reached stage 26. Note that the coexpression of Prdm13 with Neurog2 abrogates its ability to induce Tlx3. Myt1 induction by Neurog2 is in contrast not affected. Pax2 is
slightly upregulated by the coexpression of Prdm13. CC, control caps.
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Fig. 9. Prdm13 overexpression induces GABAergic and suppresses glutamatergic markers in the chick neural tube. (A–L) Immunoﬂuorescence on transverse sections of
HH24–25 chick neural tube, with the right side of the neural tube electroporated with a mouse pCIG-Prdm13 expression construct with antibodies against Pax2, Lbx1, Tlx3,
Lmx1b in red and GFP in green. Note the disappearance of the Pax2 gap of staining between the presumptive dI4 and dI6 neurons (arrow) and the Pax2 staining above dI4
(asterisk). Lbx1 is also detected more ventrally and dorsally (asterisks) upon Prdm13 overexpression. In contrast, Tlx3 in dI3/5 and Lmx1b in dI5 are decreased. High
magniﬁcation views of the control and electroporated sides in the dorsal half of the neural tube are shown in C0–C0 0 and F0–F0 0 . In contrast, in I0–I0 0 and L0–L0 0 , no GFPþ Prdm13
expressing cells are Tlx3þ or Lmx1bþ . (M) Quantiﬁcation of the number of Pax2, Tlx3, Lbx1 and Lmx1b positive cells in the different progenitor regions on the Prdm13
electroporated side compared to the contralateral, control side. Po0.05n, Po0.01nn, Po0.001nnn; (nZ3).
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such a function is not known because of lack of information about
its targets in the nervous system. Here we report the identiﬁcation
in Xenopus of a novel likely direct target of the PTF1-J complex,
Prdm13, with a key role in the control of the balance of inhibitory
versus excitatory neurons in the dorsal neural tube.
Prdm13 has histone methyltransferase activity
Prdm genes encode epigenetic transcriptional regulators. Some
members of the Prdm family have been shown to possess intrinsic
HMT activity while others act via interactions with enzymes
capable of methylating histones or catalyzing other post-
translational modiﬁcations of chromatin histone (Fog et al., 2011;
Hohenauer and Moore, 2012). We showed that Prdm13 has HMT
activity in 293T cells and have observed that it causes H3K9 and
H3K27 trimethylation (B. Van Driessche, unpublished data) which
induces repressive chromatin states. Chang et al. (2013) has shown
that Prdm13 has some function in vivo in neuronal speciﬁcation
without the PR domain. Whether Prdm13 has intrinsic HMT
activity dependent on the PR domain is an important issue that
requires further investigation.
Prdm13 expression and regulation in the dorsal caudal neural tube
Prdm13 is, together with the closely related Prdm8 gene, one of
the members of the Prdm family that has CNS speciﬁc expression
and is not detected in invertebrates (Hohenauer and Moore, 2012).
Our data shows that Prdm13 expression in Xenopus is highly
similar to that in mouse (Kinameri et al., 2008) and in zebraﬁsh
(Sun et al., 2008), suggesting evolutionary conservation of function
in vertebrates. As in those species, Prdm13 expression in the frog is
only detected in the caudal neural tube and is highly restricted
along its D/V axis. At the neural plate stage, Prdm13 expression is
detected in the region of the differentiating primary interneurons,
suggesting a role in primary neurogenesis. It is detected more
dorsally compared to Dbx1 that marks p0 progenitors and Prdm8
that deﬁnes the p0 to pMN progenitor regions (Kinameri et al.,
2008). We detected a gap of expression in between the stripes of
Prdm13 and Prdm8. This gap is likely to correspond to the Dbx1
domain of expression. In the mouse, low level of Prdm13 expres-
sion is also detected in the ventricular zone of the neural tube of
mouse E11.5 embryos in the region expressing Dbx1 (Kinameri
et al., 2008). Whether Prdm13 and Dbx1 crossregulate each other
remains to be investigated.
As in the mouse, Prdm13 in the frog is weakly expressed in the
ventricular zone and stronger staining is detected at the margin of
the VZ, suggesting that the gene may be the most active when cells
stop to proliferate and start to differentiate. Along the A/P axis, we
found that in the frog neurula and early tailbud stage embryos,
Prdm13 is restricted to the caudal hindbrain and spinal cord and
that its expression only later extends to the anterior hindbrain
region. A detailed analysis of the temporal expression of Prdm13
during embryogenesis is not available in zebraﬁsh and mouse, so it
is not clear whether Prdm13 has a similar dynamic expression in
those species. Outside the developing spinal cord, Prdm13 is also
expressed in the frog in the retina as in the mouse and zebraﬁsh
(Kinameri et al., 2008; Sun et al., 2008). No expression was
detected in the frog in olfactory placodes as reported in zebraﬁsh
(Sun et al., 2008).
Our results indicate that within both the dorsal spinal cord and
retina, Prdm13 expression overlaps with that of Ptf1a and that
Ptf1a promotes Prdm13 expression in the spinal cord. We also
observed that Prdm13 is upregulated by Ascl1. This is in accor-
dance with Ascl1 controlling GABAergic differentiation in the
dorsal spinal cord by regulating Ptf1a expression (Mizuguchi
et al., 2006; Mazurier et al., unpublished). In contrast, Neurog2
whose expression also overlaps with that of Prdm13 in the dorsal
spinal cord does not appear to regulate Prdm13. We however
observed that the combined overexpression of Ptf1a and Neurog2
induces a higher level of Prdm13 than that observed in Ptf1a alone
or Neurog2 alone injected embryos. This observation may reﬂect a
synergistic interaction between the two factors. It may however
also simply be a secondary consequence of Neurog2 proneural
activity leading to a larger number of neurons with their fate being
subsequently determined by Ptf1a.
Prdm13 is likely directly regulated by Ptf1a as it is rapidly
induced upon Ptf1a overexpression and that this induction occurs
even in the presence of the translation blocking drug cyclohex-
imide. Several Ptf1a binding regions surrounding the Prdm13 gene
were recently identiﬁed on neural tube tissue, which demon-
strates that Prdm13 is indeed a direct downstream target of Ptf1a
(Chang et al., 2013).
Intrinsic functional properties of bHLH transcription factors is
driven by speciﬁcity of protein–protein interactions or DNA bind-
ing speciﬁcity. In structure function analysis, functional differences
between bHLH proteins have been mapped to residues within the
bHLH domain (Nakada et al., 2004; Skowronska-Krawczyk et al.,
2005; Powell and Jarman, 2008). We observed that a Ptf1a/bHLH-
Neurog2-GR chimeric protein, where the Ptf1a bHLH has been
replaced with that of Neurog2, is still able to induce Prdm13,
indicating that in the case of Ptf1a, it is the sequences outside the
bHLH domain that are most important for its specify of function.
Our data indicate that the unique ability of Ptf1a to induce Prdm13
is due to the C1/C2 motifs, located in its C-terminal region, which
allow interaction with Rbp-j (Beres et al., 2006). This is supported
by the fact that in the frog (1) overexpression of Ptf1a in
combination with Rbp-j induces higher Prdm13 transcript levels
than Ptf1a alone, (2) a mutated form of Ptf1aW224A/W242A-GR
unable to interact with Rbp-j is unable to induce Prdm13 and
(3) in mouse Ptf1aW298A mutant embryos, Prdm13 was strongly
reduced in the spinal cord. Recent ChIP-seq data have shown that
Rbp-j colocalizes with several Ptf1a peaks surrounding the mouse
Prdm13 locus, further demonstrating that Prdm13 is a target of the
PTF1-J complex (Chang et al., 2013). The reduced activity of the
Ptf1a/bHLH-Neurog2-GR chimeric protein compared to the wild
type protein suggest a possible contribution of the bHLH domain
of Ptf1a to its speciﬁcity of function. This contribution, which may
be due either to some E-box binding sites preference or to some
speciﬁc protein–protein interactions, remains to be further
investigated.
Function of Prdm13 in neuronal speciﬁcation
In the dorsal spinal cord, Ptf1a act as a selector gene, promoting
GABA/glycinergic neurons and suppressing alternate fates through
Tlx3 repression (Glasgow et al., 2005; Hori et al., 2008). In the frog,
we found that knock-down of Prdm13 in embryos and in animal
cap explants reduces the ability of Ptf1a to induce the GABAergic
markers and upregulates glutamatergic determinants. Conversely,
in the chick neural tube, Prdm13 overexpression induces GABAergic
and suppresses glutamatergic markers. These results and those
similar obtained by Chang et al. (2013) indicate that Prdm13 is a
downstream target of Ptf1a that has a conserved essential function
in the control of the balance between GABAergic and glutamater-
gic neurons.
In the frog mature retina, we showed that Prdm13 is coex-
pressed with Ptf1a in the CMZ and that it is also expressed in post-
mitotic cells in the inner nuclear layer. This layer contains ama-
crine and horizontal cells, which are mainly GABAergic or glyci-
nergic, and ganglion cells which are considered mainly as
glutamatergic. Whether Prdm13 is expressed in all or a subset of
GABA and/or glycinergic neurons and is excluded from excitatory
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cells remains to be investigated. As observed in the mouse (Chang
et al., 2013), we found that Prdm13 is lost in the retina from Ptf1a
depleted embryos (Hanotel, unpublished data). Based on the
importance of Prdm13 in GABAergic cell fate within the caudal
neural tube, it is thus tempting to speculate that it also plays a role
in the retina in the suppression of the expression of non-Ptf1a
lineages. In the retina, the fates of all retinal neurons that
primarily express the inhibitory neurotransmitters GABA or gly-
cine require the expression of Ptf1a (Fujitani et al., 2006; Dullin
et al., 2007; Nakhai et al., 2007; Jusuf et al., 2011). Ptf1a alone is
however not sufﬁcient to confer subtype-speciﬁcity (Jusuf et al.,
2011). Whether Prdm13 is required downstream of Ptf1a to specify
all inhibitory neurons or whether it biases precursors towards a
speciﬁc subtype of amacrine and horizontal destinies is an
important question that remains to be addressed.
Mechanisms of action of Prdm13 in neuronal speciﬁcation
How does Prdm13 function downstream of Ptf1a to promote
Pax2þ/GABAergic over Tlx3þ/glutamatergic neuronal fate? As
many Prdm members function as repressors (Hohenauer and
Moore, 2012), one attractive possibility is that it may do so
indirectly by repressing transcription of genes such as Tlx3 that
induce the glutamatergic program and antagonize Lbx1 that
promote Pax2 and the GABAergic program (Cheng et al., 2004;
Cheng et al., 2005). This is supported by our observation that
Prdm13 overexpression in 293T cells increases the level of several
histone repressive marks (Van Driessche, unpublished data). This
has been also very recently supported by the additional observa-
tions that (1) Prdm13 occupies genomic regions near the Tlx1 and
Tlx3 genes and (2) Prdm13-bound regions have enhancer activities
that is blocked by ectopic Prdm13 (Chang et al., 2013). In their
study, Chang et al. suggest that Prdm13 acts during GABAergic
neuron differentiation through interaction with the bHLH factor
Ascl1 and the repression of its ability to activate Tlx3. Our data
suggest that Prdm13 silence glutamatergic lineage genes not only
through repression of the activity of Ascl1 but also through
repression of Neurog2 activity. Neurog2 is essential for the gen-
eration of sensory neurons, spinal motor neurons, glutamatergic
neurons in the cerebral cortex, dopaminergic neurons in the
ventral midbrain and in the developing olfactory system (Fode
et al., 1998, 2000; Ma et al., 1999; Novitch et al., 2001; Scardigli
et al., 2001; Schuurmans et al., 2004; Kele et al., 2006; Shaker
et al., 2012). Its role in the formation of GABAergic interneurons in
the spinal cord is unclear. Results of the analysis of embryos null
for Ascl1 or Neurog2 and of Ascl1/Neurog2 double knockouts
suggest that there may be a redundant function for Ascl1 and
Neurog2 in the generation of dI4 neurons (Helms et al., 2005).
Whether mPrdm13 forms a repressor complex with mNeurog2
and thus switches it from an activator to a repressor with respect
to Tlx3 gene expression, as seen with Ascl1, remains to be
addressed (Chang et al., 2013).
Our results also indicate that Prdm13 negatively self-regulates
its expression. This negative autoregulation that limits Prdm13
expression may be important to avoid to reach a level of Prdm13
that would allow unspeciﬁc binding and interference with other
factors required for GABAergic neurons. In contrast to Prdm13,
Ptf1a is not upregulated in Prdm13 morphants (Hanotel, unpub-
lished data), indicating that the increase of Prdm13 transcription is
not due to a negative retrocontrol of Prdm13 on Ptf1a expression.
Prdm13 negative autoregulation is thus likely to be due to other
mechanisms. Although there is no evidence for Prdm13 directly
binding to DNA, another possibility is a direct autorepressive
action of Prdm13.
Altogether, our gain and loss of function data identify the zinc
ﬁnger transcription factor Prdm13 as a conserved critical regulator
of GABA/glutamatergic cell fate speciﬁcation in the vertebrate
dorsal neural tube. Future work examining its biochemical proper-
ties and using genetic approaches is required to get a better
understanding of its mechanism of action and its function in other
regions of the CNS such as the retina.
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